MRL Ltd.īs Coriolus versicolor powder contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate.
This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent.
The cultivation system is proprietary, allowing for standardised production of Coriolus verisicolor. The powder biomass is then sealed in plastic containers.
Manufacturing Process of Coriolus-MRL
The Coriolus versicolor is processed under the same rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500 mg of the standardised Coriolus product.
The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.
After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.
The fungal biomass Coriolus versicolor that comprises Coriolus-MRL is certified 100 Organic in the United States by Quality Assurance International (Certificate No. 103491-A).
Chemical and Biological Proprieties
Each Tablet of Coriolus-MRL contains
Coriolus versicolor - biomass powder 500 mg
Coriolus-MRL-(in vitro Enzyme Activity) per 725 mg Tablet
Protein content 17.3 mg
Reducing sugars 14.8 mg
Protein-bound polysaccharide 91.5 mg
Glucose 2-oxidase activity 49.5 mU
Peroxidase activity 67.2 mU
Laccase activity 521.5 mU
Glucoamylase / glucansase activity 6.9 U
Protease activity 5.9 U
Superoxide dismutase (SOD) activity 77.1 mU
Cytochrome P-450 0.51 nmoles
Cytochrome P-450 reductase 11.9 mU
Secondary metabolites (Thrombin inhibitors) 59
Vegetable Magnesium Sterate